1. Home
  2. COCP vs WFF Comparison

COCP vs WFF Comparison

Compare COCP & WFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

N/A

Current Price

$1.01

Market Cap

19.2M

Sector

Health Care

ML Signal

N/A

Logo WF Holding Limited Ordinary Shares

WFF

WF Holding Limited Ordinary Shares

N/A

Current Price

$1.36

Market Cap

16.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
COCP
WFF
Founded
N/A
1984
Country
United States
Malaysia
Employees
10
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Miscellaneous manufacturing industries
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
19.2M
16.9M
IPO Year
2011
2024

Fundamental Metrics

Financial Performance
Metric
COCP
WFF
Price
$1.01
$1.36
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $8.00
N/A
AVG Volume (30 Days)
33.0K
★ 60.3M
Earning Date
11-13-2026
10-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 54.65
N/A
EPS
N/A
★ N/A
Revenue
★ $12,712,091.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.76
$0.05
52 Week High
$2.03
$50.60

Technical Indicators

Market Signals
Indicator
COCP
WFF
Relative Strength Index (RSI) 43.22 49.17
Support Level $0.98 $1.21
Resistance Level $1.10 $2.04
Average True Range (ATR) 0.06 1.26
MACD 0.00 -0.14
Stochastic Oscillator 42.57 8.49

Price Performance

Historical Comparison
COCP
WFF

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

About WFF WF Holding Limited Ordinary Shares

WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings, and other custom-made FRP products. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance. Geographically, the company generates the majority of its revenue from Australia.

Share on Social Networks: